Mode
Text Size
Log in / Sign up
N/A N=158 Randomized Double-blind Supportive Care

RCT Social Cognition Training and Therapeutic Alliance Focused Therapy for Persons With Severe Mental Illness

Mental Disorders

Enrolled (actual)
158
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: The Face Emotion Identification Task (FEIT) — 12.83; 12.47; 11.55; 13.65 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
SCIT (Behavioral); TAFT (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Bar-Ilan University, Israel
Primary completion
Jul 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
The Face Emotion Identification Task (FEIT)
12.83; 12.47; 11.55; 13.65; 13.65; 12.00
PRIMARY
Faux-Pas Task
30.79; 30.11; 27.95; 34.41; 31.89; 29.20
PRIMARY
Ambiguous Intentions Hostility Questionnaire (AIHQ)
10.93; 12.63; 11.64; 10.19; 11.64; 12.06
PRIMARY
Social Skill Performance Assessment
47.13; 48.90; 54; 52.39; 50.20; 49.70
SECONDARY
Wisconsin Social Quality of Life Scale.
4.48; 5.22; 4.78; 4.61; 5.23; 4.77

Summary

The study evaluates the effectiveness of the social cognition and interaction training (SCIT), in comparison to both therapeutic alliance focused therapy (TAFT) and treatment as usual (TAU) among persons with severe mental illness. Study purpose: 1) Assess the effectiveness of the SCIT and TAFT interventions, 2) Assess the processes that putatively contribute to the SCIT and TAFT outcomes. Method: A Randomized Controlled Trial (RCT) with approximately one hundred and fifty persons with severe mental illness will be carried out in different psychiatric rehabilitation units and clinics in Israel. To assess the relative effectiveness of the SCIT and TAFT interventions with persons with severe mental illness, both interventions will be compared to treatment as usual (TAU). Clinicians will be trained in both interventions, and outcome measures, including social quality of life and social functioning, as well as mediating processes, including the identification of affective states, ToM, attribution errors and therapeutic alliance, will be assessed. Cognitive functioning and symptom severity will be treated as covariates. Statistical analyses will include analysis of variance which takes into consideration attrition, effect size, mediation processes and covariates.

Eligibility Criteria

Inclusion criteria

  • Diagnosis of severe mental disorders (schizophrenia, schizoaffective, bi-polar, depression).
  • Ability to provide informed consent.
  • Ability to read and write in Hebrew.

Exclusion criteria

  • Co-morbid nuerological condition.
  • Hospitalization in the last 6 months.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02380885). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search